What is thrombocytopenia, the rare blood condition possibly linked to the AstraZeneca vaccine?
By Anthony Zulli, Associate professor, Victoria University
Maja Husaric, Senior Lecturer; MD, Victoria University
Maximilian de Courten, Professor in Global Public Health and Director of the Mitchell Institute, Victoria University
Vasso Apostolopoulos, Professor of Immunology and Associate Provost, Research Partnerships, Victoria University
Scientists have called it "vaccine-induced prothrombotic immune thrombocytopenia", or VIPIT. The condition is characterised by a shortage of platelets in the blood.
Read complete article
© The Conversation
- Thursday, April 8, 2021